Cargando…
Can circulating tumor DNA be used for direct and early stage cancer detection?
In the August 16th issue of Science Translational Medicine, Phallen et al propose a method for early cancer diagnosis by using circulating tumor DNA (1). One major advance of this paper includes optimized sequencing of cell-free/circulating tumor DNA (ctDNA) without knowledge of tumor mutations. Eva...
Autores principales: | Diamandis, Eleftherios P, Fiala, Clare |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000 Research Limited
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5754742/ https://www.ncbi.nlm.nih.gov/pubmed/29333251 http://dx.doi.org/10.12688/f1000research.13440.1 |
Ejemplares similares
-
Utility of circulating tumor DNA in cancer diagnostics with emphasis on early detection
por: Fiala, Clare, et al.
Publicado: (2018) -
Circulating tumor DNA for personalized lung cancer monitoring
por: Fiala, Clare, et al.
Publicado: (2017) -
New approaches for detecting cancer with circulating cell-free DNA
por: Fiala, Clare, et al.
Publicado: (2019) -
Can Circulating Tumor DNA Support a Successful Screening Test for Early Cancer Detection? The Grail Paradigm
por: Pons-Belda, Oscar D., et al.
Publicado: (2021) -
Multi Cancer Early Detection by Using Circulating Tumor DNA—The Galleri Test. Reply to Klein et al. The Promise of Multicancer Early Detection. Comment on “Pons-Belda et al. Can Circulating Tumor DNA Support a Successful Screening Test for Early Cancer Detection? The Grail Paradigm. Diagnostics 2021, 11, 2171”
por: Pons-Belda, Oscar D., et al.
Publicado: (2022)